Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rAvPAL-PEG (Palynziq) in Phenylketonuria
NCT01212744Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Mar 2011
- Primary completion
- Apr 2015
- Modality
- PEGylated Peptides, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegvaliase in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Mar 2011; status: completed.
02
Drugs
pegvaliase
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT01212744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01212744.